At Elihu Institute for Pain Management, we are always on the lookout for new and innovative treatments for chronic pain. That is why we are excited to announce that Abbott has won Food and Drug Administration approval for a new spinal cord stimulation system called Proclaim Plus.
This system is designed to treat multi-site and evolving pain, offering coverage across up to six areas and allowing physicians to adjust the programming in response to the changing needs of the patient. This is a significant advancement in the treatment of chronic pain, as many patients experience pain in multiple areas of their body.
Securing FDA approval is a major milestone for Abbott, and it gives the company a new angle to push as it seeks to increase its share of the spinal cord stimulation market. At Elihu Institute for Pain Management, we are excited to be at the forefront of this new technology and to be able to offer it to our patients.
If you are living with chronic pain and are looking for effective treatment options, please contact Elihu Institute for Pain Management today to learn more about how Proclaim Plus can help you.